Benzyl Carbamate

Benzyl Carbamate

SCHEMBL5783812

CC(C)C(=O)O.NC(=O)OCc1ccccc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.56
▸ KMT2A Q03164 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ SLC15A1 P46059 1/20 0.50
▸ SLC6A2 P23975 1/20 0.50
▸ SLC6A3 Q01959 1/20 0.50
▸ SLC1A3 P43003 2/20 0.47
▸ SLC1A2 P43004 2/20 0.47
▸ SLC1A1 P43005 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzyl Carbamate SCHEMBL28618318 0.93 ALDH1A1 (0.60) ALDH1A1KMT2ALMNATDP1MAPK1
Benzyl Carbamate SCHEMBL11299634 0.91 ALDH1A1 (0.55) ALDH1A1KMT2ALMNATDP1MAPK1
Benzyl Carbamate SCHEMBL6992838 0.89 ALDH1A1 (0.64) ALDH1A1KMT2ALMNATDP1MAPK1
Benzyl Carbamate SCHEMBL8592590 0.89 ALDH1A1 (0.64) ALDH1A1KMT2ALMNATDP1MAPK1
Benzyl Carbamate SCHEMBL30227819 0.89 ALDH1A1 (0.63) ALDH1A1KMT2ALMNATDP1MAPK1
Benzyl Carbamate SCHEMBL10700633 0.89 ALDH1A1 (0.63) ALDH1A1KMT2ALMNATDP1MAPK1
Benzyl Carbamate SCHEMBL30227887 0.89 ALDH1A1 (0.63) ALDH1A1KMT2ALMNATDP1MAPK1
Benzyl Carbamate SCHEMBL1697 0.89 ALDH1A1 (0.63) ALDH1A1KMT2ALMNATDP1MAPK1
Benzyl Carbamate SCHEMBL28086051 0.87 ALDH1A1 (0.62) ALDH1A1KMT2ALMNATDP1MAPK1
Benzyl Carbamate SCHEMBL27278367 0.87 ALDH1A1 (0.68) ALDH1A1KMT2ALMNATDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060189591-A1 Five-membered heterocyclic derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 — — US disclosed
EP-1621537-A1 FIVE-MEMBERED HETEROCYCLIC DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-02-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189591-A1 Five-membered heterocyclic derivative PTGS1, PTGIS, PTGS2 ALDH1A1 251/4885KMT2A 4143/4885LMNA 3156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback